Diagnosis of invasive fungal infections in immunocompromised children

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1328-1334

  Dornbusch, H J ^a   Groll, A ^b   Walsh, T J ^c  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Children; Diagnosis; Fungal infections; Imaging; Non culture methods; Review

Indexed keywords

BETA 1,3 GLUCAN; FUNGAL DNA; GALACTOMANNAN; MANNAN;

ASPERGILLUS TERREUS; CANDIDIASIS; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CYTOLOGY; DIAGNOSTIC IMAGING; DNA SEQUENCE; ENVIRONMENTAL EXPOSURE; ENZYME ASSAY; FUNGUS CULTURE; FUNGUS ISOLATION; FUSARIUM; HIGH RISK PATIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INVASIVE ASPERGILLOSIS; LIVER BIOPSY; LUNG ASPERGILLOSIS; LUNG LAVAGE; MOLECULAR BIOLOGY; MYCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCEDOSPORIUM; SENSITIVITY AND SPECIFICITY;

EID: 77956099067     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03336.x     Document Type: Review

References (84)

1. von Eiff M, Roos N, Schulten R, Hesse M, Zuehlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995, 62:341-347.
2. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008, 47:503-509.
3. Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005, 49:3640-3645.
4. Garey KW, Rege M, Pai MP. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 2006, 43:25-31.
5. Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tissue-proven invasive candidiasis: disseminated versus single organ infection. Diagn Microbiol Infect Dis 1993, 17:103-109.
6. Caillot D, Casanovas O, Bernard A. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997, 15:139-147.
7. Caillot D, Couaillier J-F, Bernard A. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001, 19:253-259.
8. Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM. Radiologic-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr 1987, 11:534-536.
9. Greene RE, Schlamm HT, Oestmann JW. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007, 44:373-379.
10. Denning DW. Early diagnosis of invasive aspergillosis. Lancet 2000, 355:423-424.
11. Lee YR, Choi YW, Lee KJ. CT halo sign: the spectrum of pulmonary diseases. Br J Radiol 2005, 78:862-865.
12. Thomas KE, Owens CM, Veys PA, Novelli V, Costoli V. The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 2003, 33:453-460.
13. Burgos A, Zaoutis TE, Dvorak CC. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics 2008, 121:e1286-e1294.
14. Taccone A, Occhi M, Garaventa A, Manfredini L, Viscoli C. CT of invasive pulmonary aspergillosis in children with cancer. Pediatr Radiol 1993, 23:177-180.
15. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2009, 357:2277-2284.
16. Masood A, Sallah S. Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment. Leuk Res 2005, 29:493-501.
17. Rudolph J, Rodenwaldt J, Ruhnke M, Hamm B, Kopka L. Unusual enhancement pattern of liver lesions in hepatosplenic candidiasis. Acta Radiol 2004, 45:499-503.
18. Pastakia B, Shawker TH, Thaler M, O'Leary T, Pizzo PA. Hepatosplenic candidiasis: wheels within wheels. Radiology 1988, 166:417-421.
19. Görg C, Weide R, Schwerk WB, Köppler H, Havemann K. Ultrasound evaluation of hepatic and splenic microabscesses in the immunocompromised patient: sonographic patterns, differential diagnosis, and follow-up. J Clin Ultrasound 1994, 22:525-529.
20. Sallah S, Semelka R, Kelekis N, Worawattanakul S, Sallah W. Diagnosis and monitoring response to treatment of hepatosplenic candidiasis in patients with acute leukemia using magnetic resonance imaging. Acta Haematol 1998, 100:77-81.
21. Groll AH, Walsh TJ. Antifungal chemotherapy: advances and perspectives. Swiss Med Wkly 2002, 132:303-311.
22. Meyer M-H, Letscher-Bru V, Jaulhac B. Comparison of mycosis IC/F and plus aerobic/F media for diagnosis of fungemia by the Bactec 9240 system. J Clin Microbiol 2004, 42:773-777.
23. Terlecka JA, du Cros PA, Orla Morrissey C, Spelman D. Rapid differentiation of Candida albicans from non-albicans species by germ tube test directly from BacTAlert blood culture bottles. Mycoses 2007, 50:48-51.
24. Simoneau E, Kelly M, Labbe AC, Roy J, Laverdiere M. What is the clinical significance of positive blood cultures with Aspergillus sp. in hematopoietic stem cell transplant recipients? A 23 year experience. Bone Marrow Transplant 2005, 35:303-306.
25. Mennink-Kersten M, Verweij PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin North Am 2006, 20:711-727.
26. DePauw B, Walsh TJ, Donelly JP. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008, 46:1813-1821.
27. Maertens J, Verhaegen J, Lagrou K. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001, 97:1604-1610.
28. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using galactomannan assay: a metaanalysis. Clin Infect Dis 2006, 42:1417-1427.
29. Viscoli C, Machetti M, Gazzola P. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 2002, 40:1496-1499.
30. Klont RR, Menninck-Kersten MA, Verweij PE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 2004, 39:1467-1474.
31. Hayden R, Pounds S, Knapp K. Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis. Pediatr Infect Dis J 2008, 27:815-819.
32. Herbrecht R, Letscher-Bru V, Oprea C. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002, 20:1898-1906.
33. Castagnola E, Furfaro E, Caviglia I. Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation. Clin Microbiol Infect 2010, 16:1197-1203.
34. Roilides E. Early diagnosis of invasive aspergillosis in children. Med Mycol 2006, 44:S199-S205.
35. Walsh TJ, Shoham S, Petraitiene R. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004, 42:4744-4748.
36. Viscoli C, Machetti M, Cappellano P. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004, 38:913-916.
37. Aubry A, Porcher R, Bottero J. Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders. J Clin Microbiol 2006, 44:389-394.
38. Mennink-Kersten MA, Ruegebrink D, Klont RR. Bifidobacterial lipoglycan as a new cause for false-positive Platelia Aspergillus enzyme-linked immunosorbent assay reactivity. J Clin Microbiol 2005, 43:3925-3931.
39. Steinbach WJ, Addison RM, McLaughlin L. Prospective Aspergillus galactomannan antigen testing in pediatric hematopoietic stem cell transplant recipients. Pediatr Infect Dis J 2007, 26:558-564.
40. Desai R, Ross LA, Hoffman JA. The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis. Pediatr Infect Dis J 2009, 28:283-286.
41. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004, 42:5517-5522.
42. Francesconi A, Kasai M, Petraitiene R. Characterization and comparison of galactomannan enzyme immunoassay and quantitative real-time PCR assay for detection of Aspergillus fumigatus in bronchoalveolar lavage fluid from experimental invasive pulmonary aspergillosis. J Clin Microbiol 2006, 44:2475-2480.
43. Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka K, Hara K. (1→3)-β-D glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. J Clin Lab Anal 1995, 9:334-339.
44. Obayashi T, Yoshida M, Mori T. Plasma (1,3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995, 345:17-20.
45. Girouard G, Lachance C, Pelletier R. Observations of (1,3)-beta-D-glucan detection as a diagnostic tool in endemic mycoses caused by Histoplasma or Blastomyces. J Med Mycol 2007, 56:1001-1002.
46. Kami M, Fukui T, Ogawa S. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 2001, 33:1504-1512.
47. Odabasi Z, Mattiuzzi G, Estey E. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004, 39:199-205.
48. Ostrosky-Zeichner L, Alexander BD, Kett DH. Multicenter clinical evaluation of the (1,3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005, 41:654-659.
49. Pazos C, Ponton J, Del Palacio A. Contribution of (1-3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005, 43:299-305.
50. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1,3) beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005, 43:5957-5962.
51. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1,3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008, 46:1009-1013.
52. Ellis M, Al-Ramadi B, Finkelman M. Assessment of the clinical utility of serial beta D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008, 57(Pt 3):287-295.
53. Senn L, Robinson JO, Schmidt S. 1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008, 46:878-885.
54. Mennink-Kersten MA, Warris A, Verweij PE. Detection of circulating 1,3-beta-D glucan in patients receiving intravenous amoxicillin-clavulanic acid. N Engl J Med 2006, 354:2834-2835.
55. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. Reactivity of (1→3)-β-D glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother 2006, 50:3450-3453.
56. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009, 47:129-133.
57. Roilides E, Farmaki E, Evdoridou J. Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates. Eur J Clin Microbiol Infect Dis 2004, 23:745-750.
58. Benjamin DK, Stoll BJ, Fanaroff AA. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117:84-92. National Institute of Child Health and Human Development Neonatal Research Network.
59. Cohen-Wolkowiez M, Smith PB, Mangum B. Neonatal Candida meningitis: significance of cerebrospinal fluid parameters and blood cultures. J Perinatol 2007, 27:97-100.
60. Petraitiene R, Petraitis V, Hope WW. Cerebrospinal fluid and plasma (1→3)-beta D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrob Agents Chemother 2008, 52:4121-4129.
61. Hope WW, Mickiene D, Petraitis V. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J Infect Dis 2008, 197:163-171.
62. Smith PB, Benjamin DJ, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1,3-β-D-glucan levels in children: preliminary data for diagnostic use of the β-glucan assay in a pediatric setting. Vacc Immunol 2007, 14:924-925.
63. Ellis M, Al-Ramadi B, Bernsen R, Kristensen J, Alizadeh H, Hedstrom U. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever. J Med Microbiol 2009, 58(Pt 5):606-615.
64. Lunel FM, Mennink-Kersten MA, Ruegebrink D. Value of Candida serum markers in patients with invasive candidiasis after myeloablative chemotherapy. Diagn Microbiol Infect Dis 2009, 64:408-415.
65. Oliveri S, Trovato L, Betta P, Romeo MG, Nicoletti G. Experience with the Platelia Candida ELISA for the diagnosis of invasive candidosis in neonatal patients. Clin Microbiol Infect 2008, 14:391-393.
66. Einsele H, Loeffler J. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients. Clin Microbiol Infect Dis 2008, 14:37-45.
67. O'Sullivan CE, Kasai M, Francesconi A. Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer (FRET) technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis. J Clin Microbiol 2003, 41:5676-5682.
68. Kasai M, Francesconi A, Petraitiene R. Use of quantitative real-time PCR to study the kinetics of extracellular DNA released from Candida albicans, with implications for diagnosis of invasive candidiasis. J Clin Microbiol 2006, 44:143-150.
69. Kasai M, Harrington SM, Francesconi A. Detection of molecular biomarkers for Rhizopus spp., Mucor spp., and Cunninghamella spp. by quantitative PCR and melt curve analysis in plasma, bronchoalveolar lavage, and lung tissue in experimental pulmonary zygomycosis. J Clin Microbiol 2008, 46:3690-3702.
70. Hebart H, Loeffler J, Meisner C. Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis 2000, 181:1713-1719.
71. Lass-Flörl C, Aigner J, Gunsilius E. Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. Br J Haematol 2001, 113:180-184.
72. Hebart H, Klingspor L, Klingebiel T. A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allogeneic stem cell transplantation. Bone Marrow Transplant 2009, 43:553-561.
73. Lass-Floerl C, Resch G, Nachbaur D. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection immunocompromised patients. Clin Infect Dis 2007, 45:e101-e104.
74. Buchheidt D, Baust C, Skladny H. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 2001, 33:428-435.
75. Hummel M, Spiess B, Roder J. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J Med Microbiol 2009, 58(Pt 10):1291-1297.
76. El-Mahallawy HA, Shaker HH, Ali Helmy H, Mostafa T, Razak Abo-Sedah A. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients. Med Mycol 2006, 44:733-739.
77. Loeffler J, Hebart H, Sepe S, Schumacher U, Klingebiel T, Einsele H. Detection of PCR amplified fungal DNA by using a PCR-ELISA system. Med Mycol 1998, 36:275-279.
78. Loeffler J, Schmidt K, Hebart H, Schumacher U, Einsele H. Automated extraction of medically important yeast species and filamentous fungi by using the MagNa Pure LC system. J Clin Microbiol 2002, 40:2240-2243.
79. Loeffler J, Henke N, Hebart H. Quantification of fungal DNA by using Fluorescence Resonance Energy Transfer and the Light Cycler system. J Clin Microbiol 2000, 38:586-590.
80. Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B. Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 2007, 45:906-914.
81. Basková L, Landlinger C, Preuner S, Lion T. The Pan-AC assay: a single-reaction real time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J Med Microbiol 2007, 56(Pt 9):1167-1173.
82. Wallet F, Nseir S, Baumann L. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect 2010, 16:774-779.
83. Shepard JR, Addison RM, Alexander BD. Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 2008, 46:50-55.
84. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009, 9:89-96.